Title | Author(s) | Issue date | ???itemlist.??? |
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment - a prospective, controlled study | Georgiadis, A. N.; Papavasiliou, E. C.; Lourida, E. S.; Alamanos, Y.; Kostara, C.; Tselepis, A. D.; Drosos, A. A. | 24-Nov-2015 | - |
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study | Georgiadis, A. N.; Papavasiliou, E. C.; Lourida, E. S.; Alamanos, Y.; Kostara, C.; Tselepis, A. D.; Drosos, A. A. | 24-Nov-2015 | - |
Effects of eprosartan on serum metabolic parameters in patients with essential hypertension | Rizos, E. C.; Spyrou, A.; Liberopoulos, E. N.; Papavasiliou, E. C.; Saougos, V.; Tselepis, A. D.; Elisaf, M. S. | 24-Nov-2015 | - |
The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome | Filippatos, T. D.; Liberopoulos, E. N.; Kostapanos, M.; Gazi, I. F.; Papavasiliou, E. C.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S. | 24-Nov-2015 | - |
Epoetin alpha increases plasma HDL levels and HDL-associated PAF-acetylhydrolase activity in patients with chronic renal failure | Papavasiliou, E. C.; Gouva, C.; Siamopoulos, K. C.; Tselepis, A. D. | 24-Nov-2015 | - |
Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: Effect of long-term therapy with erythropoietin | Papavasiliou, E. C.; Gouva, C.; Siamopoulos, K. C.; Tselepis, A. D. | 24-Nov-2015 | - |
Erythropoietin administration in patients with chronic renal failure prevents the decrease in RBC-associated antioxidant enzyme activities | Papavasiliou, E. C.; Gouva, C.; Katopodis, K. P.; Nikolopoulos, P.; Tselepis, A. D.; Siamopoulos, K. C. | 24-Nov-2015 | - |
High postprandial triglyceridemia in patients with type 2 diabetes and microalbuminuria | Tentolouris, N.; Stylianou, A.; Lourida, E.; Perrea, D.; Kyriaki, D.; Papavasiliou, E. C.; Tselepis, A. D.; Katsilambros, N. | 24-Nov-2015 | - |
Long-term treatment with EPO increases serum levels of high-density lipoprotein in patients with CKD | Siamopoulos, K. C.; Gouva, C.; Katopodis, K. P.; Tzallas, C.; Nikolopoulos, P.; Papavasiliou, E. C.; Tselepis, A. D. | 24-Nov-2015 | - |
PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin | Papavasiliou, E. C.; Gouva, C.; Siamopoulos, K. C.; Tselepis, A. D. | 24-Nov-2015 | - |
Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A(2) | Lourida, E. S.; Georgiadis, A. N.; Papavasiliou, E. C.; Papathanasiou, A. I.; Drosos, A. A.; Tselepis, A. D. | 24-Nov-2015 | - |
Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with beta-thalassemia | Tselepis, A. D.; Hahalis, G.; Tellis, C. C.; Papavasiliou, E. C.; Mylona, P. T.; Kourakli, A.; Alexopoulos, D. C. | 24-Nov-2015 | - |
Platelet derived microparticles inhibit Cu2+-induced LDL oxidation | Mitsios, J. V.; Lourida, E. S.; Papavasiliou, E. C.; Tselepis, A. D. | 24-Nov-2015 | - |
Production and secretion of the lipoprotein-associated phospholipase A2 (LpPLA2) from blood monocytes of patients with early rheumatoid arthritis: Effect of disease modifying antirheumatic drugs administration | Papavasiliou, E. C.; Georgiadis, A. N.; Drosos, A. A.; Tselepis, A. D. | 24-Nov-2015 | - |